As IL-1 is a major contributor to osteoarthritis pathogenesis, stimulating chondrocytes and synovial fibroblasts to upregulate matrix metalloproteases that damage the cartilage, the blockade of this cytokine offers important benefits (Richards et al., 2016). Here, IL1B is linked to osteoarthritis.